Join The Discussion

 

Texas has old, new candidates to offer as presidential hopefuls

The Republican Party has long been riven between its establishment and conservative wings, a split that plays out every four years in the race for the White House.

read more >

Two from Fort Worth appointed by Gov. Abbott to university boards

Steve Hicks, a University of Texas System regent who has been a vocal opponent of regents who have criticized the system’s flagship campus in Austin, was reappointed to the board by Gov. Greg Abbott on Thursday. 

read more >

Fort Worth draws closer to deal with Lancaster developer

City staff are planning to introduce the developer Feb. 3 at a meeting of the City Council's Housing and Economic Development Committee.

read more >

Compass BBVA names Happel CEO for Fort Worth

BBVA Compass has appointed Brian Happel, most recently the Fort Worth city president, its chief executive officer of Fort Worth.

read more >

Two Fort Worth Baylor medical properties acquired

Baylor Surgical Hospital of Fort Worth and Baylor Surgical Hospital Integrated Medical Facility are among three facilities acquired by Carter Validus Mission Critical REIT II Inc.

read more >

 

Alcon partners with Google to develop smart contact lens

The Smart Lens prototype. Photo courtesy of Alcon. 

www.alcon.com/

Swiss drug maker Novartis Group said July 15 that its eye care unit, Fort Worth-based Alcon, will join with a division of Google Inc. to develop and market a smart contact lens for all ocular medical uses.
The smart lens technology involves non-invasive sensors, microchips and other miniaturized electronics that are embedded within contact lenses.
Google’s new smart lens technology has the potential to help diabetic patients manage their body’s glucose and help people with presbyopia to restore their eyes’ natural autofocus on near objects.


“We are looking forward to working with Google to bring together their advanced technology and our extensive knowledge of biology to meet unmet medical needs,” said Novartis CEO Joseph Jimenez. “This is a key step for us to go beyond the confines of traditional disease management, starting with the eye.”
Under the new agreement, Google[x], a team within Google, will bring its expertise in miniaturized electronics, microfabrication and low power chips, while Alcon will provide the medical know-how in physiology and visual performance of the eye as well as commercialization of contact and intraocular lenses.
The transaction remains subject to anti-trust approvals.
The three Alcon businesses – surgical, pharmaceutical and vision care – generated net sales of $10.5 billion in 2013. Alcon has more than 25,000 employees worldwide, with operations in 75 countries and products available in 180 markets.

Betty Dillard
bdillard@bizpress.net
 

< back

Email   email
hide
Catch
How 'bout them Cowboys?